MSR79 Matching Plus Regression Adjustment for the Estimation of the Average Treatment Effect on Survival Outcomes: A Case Study with Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma
Abstract
Authors
D. Di Maio S. Mitchell S. Batson E. Keeney H. Thom